ContraFect Corporation (CFRXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 2.88 Million USD | -11.79% |
| 2021 | 3.26 Million USD | -9.36% |
| 2020 | 3.6 Million USD | -7.51% |
| 2019 | 3.89 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 2.66 Million USD | -3.93% |
| 2023 Q1 | 2.77 Million USD | -3.71% |
| 2023 Q3 | 2.55 Million USD | -4.2% |
| 2022 Q1 | 3.17 Million USD | -2.82% |
| 2022 Q2 | 3.07 Million USD | -3.02% |
| 2022 Q4 | 2.88 Million USD | -3.32% |
| 2022 Q3 | 2.98 Million USD | -3.18% |
| 2021 Q3 | 3.35 Million USD | 0.0% |
| 2021 Q4 | 3.26 Million USD | -2.62% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 93.008% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 30.106% |
| SQZ Biotechnologies Company | 27.47 Million USD | 89.513% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 93.358% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 90.322% |
| Mesoblast Limited | 118.7 Million USD | 97.573% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -203.816% |
| Genus plc | 233.1 Million USD | 98.764% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 1.685% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -114.426% |
| Marizyme, Inc. | 18.71 Million USD | 84.608% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -284.133% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -2026.403% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -99.195% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -23.863% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 49.084% |
| MultiCell Technologies, Inc. | 202.58 USD | -1422054.211% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 94.989% |
| EV Biologics, Inc. | 1.49 Million USD | -92.741% |
| Q BioMed Inc. | 4.1 Million USD | 29.902% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 91.296% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -357.246% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -134.54% |
| Biomind Labs Inc. | 735.54 Thousand USD | -291.684% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 98.321% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 77.833% |
| Skye Bioscience, Inc. | 4.61 Million USD | 37.577% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -224.414% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1935.783% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 50.929% |
| IMV Inc. | 28.88 Million USD | 90.026% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -11101.835% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -27.569% |
| GB Sciences, Inc. | 1.75 Million USD | -63.758% |
| Alpha Cognition Inc. | 1.22 Million USD | -136.076% |
| HST Global, Inc. | 98.31 Thousand USD | -2830.258% |
| CSL Limited | 12.18 Billion USD | 99.976% |
| Halberd Corporation | 150 Thousand USD | -1820.667% |
| Enzolytics Inc. | 996.33 Thousand USD | -189.159% |
| Resverlogix Corp. | 6.49 Million USD | 55.615% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -503.351% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -1027.187% |
| argenx SE | 20 Million USD | 85.595% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 93.676% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -6.361% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -28076.039% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.31% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -1336.077% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -20.156% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1156.482% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 95.741% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 4.798% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -700.923% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 85.827% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1838.058% |
| BioStem Technologies, Inc. | 4.71 Million USD | 38.851% |
| ONE Bio Corp. | 19.71 Million USD | 85.387% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -1051.562% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -1058.331% |
| Agentix Corp. | 50 Thousand USD | -5662.0% |
| LadRx Corporation | 33.6 Thousand USD | -8472.874% |
| Cell Source, Inc. | 9.25 Million USD | 68.868% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -280.982% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -280.982% |
| NovAccess Global Inc. | 2.19 Million USD | -30.962% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 59.267% |
| Itoco Inc. | 228.37 Thousand USD | -1161.511% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -1265.565% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 42.183% |
| Kadimastem Ltd | 891.22 Thousand USD | -223.263% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -616.936% |
| CytoDyn Inc. | 30.07 Million USD | 90.421% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -494.899% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -718.822% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 63.158% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -2251.837% |
| Rebus Holdings, Inc. | 310 Thousand USD | -829.355% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 39.159% |
| International Stem Cell Corporation | 4.17 Million USD | 31.044% |
| Bioxytran, Inc. | 1.92 Million USD | -49.662% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -4516.026% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -32.101% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 65.356% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 66.441% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -85.216% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -975.0% |
| Neutra Corp. | 54.15 Thousand USD | -5219.817% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -57.432% |
| PureTech Health plc | 25.51 Million USD | 88.707% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -135.332% |
| IXICO plc | 472.02 Thousand USD | -510.352% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 81.414% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 95.373% |
| CSL Limited | 12.18 Billion USD | 99.976% |
| Cellectis S.A. | 92.77 Million USD | 96.895% |